Daylight saving time novel coronavirus pneumonia has been diagnosed at 132046206 (April 7th) in Beijing, and 2867242 cases have been reported in the world, according to the latest real-time statistics from the World Health Organization. At 15:34 on the morning of 15:34 in Central Europe, the total number of confirmed cases of new crown pneumonia was up to 10% in the world. 7 new cases of novel coronavirus pneumonia were confirmed in 517585 new cases worldwide, with 9264 new deaths.
Who: possible causal relationship between AstraZeneca and thrombocytopenia and thrombosis
The novel coronavirus pneumonia vaccine Committee has released a report on the safety of the new crown vaccine in AstraZeneca on 7 May. The statement said that the new crown pneumonia Subcommittee of the world Vaccine Safety Advisory Committee of the World Health Organization has assessed the reports of thrombocytopenia and thrombocytopenia after the new crown vaccine.
The committee also evaluated the latest information provided by the European drug administration and the British drug and health products regulatory agency, and concluded that there is a possible causal relationship between the AstraZeneca vaccine and thrombosis and thrombocytopenia, but it has not yet been confirmed. Special research is needed to fully understand the potential relationship. The WHO Global Advisory Committee on vaccine safety is collecting and evaluating more data.
European Drug Administration: thrombosis should be listed as a rare side effect of AstraZeneca vaccine
On April 7, local time, the European Drug Administration issued a statement saying its drug alert risk assessment committee concluded that abnormal thrombocytopenia symptoms should be listed as a very rare side effect of AstraZeneca vaccine, but the overall benefit of vaccination was still greater than risk.
The UK may stop young people from injecting aslikam new crown vaccine
Local time on April 7, according to British media reports, the British drug and health products Regulatory Authority (MHRA) believes that there may be a link between the AstraZeneca vaccine and "extremely rare and unlikely" low platelet thrombosis.
The British government has decided to provide young people aged 18-29 with an alternative to the new crown vaccine jointly developed by AstraZeneca and Oxford University.
